Data on patients with uncontrolled type 2 diabetes and depression revealed that those who underwent cognitive behavioral therapy for adherence and depression attained better A1C levels and exhibited greater adherence to oral medication and self-monitoring of blood glucose at four months compared with those in the Enhanced Treatment as Usual arm. The findings were published in Diabetes Care.

Full Story:

Related Summaries